PH31258A - New use of ropivacaine. - Google Patents

New use of ropivacaine.

Info

Publication number
PH31258A
PH31258A PH48413A PH48413A PH31258A PH 31258 A PH31258 A PH 31258A PH 48413 A PH48413 A PH 48413A PH 48413 A PH48413 A PH 48413A PH 31258 A PH31258 A PH 31258A
Authority
PH
Philippines
Prior art keywords
pct
ropivacaine
new use
sec
date
Prior art date
Application number
PH48413A
Other languages
English (en)
Inventor
Eek Arne Toraka
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH31258(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of PH31258A publication Critical patent/PH31258A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Air Conditioning Control Device (AREA)
  • Steroid Compounds (AREA)
  • Electromechanical Clocks (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Particle Accelerators (AREA)
  • Medicinal Preparation (AREA)
PH48413A 1993-06-28 1994-06-09 New use of ropivacaine. PH31258A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use

Publications (1)

Publication Number Publication Date
PH31258A true PH31258A (en) 1998-06-18

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
PH48413A PH31258A (en) 1993-06-28 1994-06-09 New use of ropivacaine.

Country Status (32)

Country Link
US (2) US5670524A (enExample)
EP (1) EP0706395B1 (enExample)
JP (1) JP3725541B2 (enExample)
CN (1) CN1074918C (enExample)
AT (1) ATE216237T1 (enExample)
BR (1) BR9406865A (enExample)
CA (1) CA2165446C (enExample)
CZ (1) CZ283300B6 (enExample)
DE (2) DE706395T1 (enExample)
DK (1) DK0706395T3 (enExample)
EE (1) EE03205B1 (enExample)
ES (1) ES2099048T3 (enExample)
FI (1) FI956269L (enExample)
GR (1) GR970300013T1 (enExample)
HU (1) HU218949B (enExample)
IL (1) IL110006A (enExample)
IS (1) IS4174A (enExample)
LT (1) LT3449B (enExample)
LV (1) LV12918B (enExample)
MY (1) MY119360A (enExample)
NO (1) NO955313D0 (enExample)
NZ (1) NZ268110A (enExample)
PH (1) PH31258A (enExample)
PL (1) PL175518B1 (enExample)
PT (1) PT706395E (enExample)
RU (1) RU2152215C1 (enExample)
SA (1) SA94150010B1 (enExample)
SE (1) SE9302218D0 (enExample)
SG (1) SG49078A1 (enExample)
SK (1) SK280111B6 (enExample)
TW (1) TW285640B (enExample)
WO (1) WO1995000148A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
CA2294950C (en) * 1997-07-21 2009-04-07 Darwin Discovery Limited Levobupivacaine and its use
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
WO2009061497A1 (en) 2007-11-07 2009-05-14 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
AU2013257727B2 (en) * 2012-05-10 2016-04-28 Cellixbio Private Limited Compositions and methods for the treatment of local pain
CN104427977B (zh) * 2012-05-10 2018-02-02 佩因拉佛姆有限公司 局部麻醉剂的储库制剂及其制备方法
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
NZ710740A (en) 2013-02-28 2020-06-26 Dermira Inc Glycopyrrolate salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560367B2 (en) * 1983-08-01 1987-04-02 Astra Lakemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
JPH09500620A (ja) 1997-01-21
CN1074918C (zh) 2001-11-21
EE03205B1 (et) 1999-08-16
GR970300013T1 (en) 1997-05-31
WO1995000148A1 (en) 1995-01-05
CA2165446A1 (en) 1995-01-05
EP0706395A1 (en) 1996-04-17
ES2099048T1 (es) 1997-05-16
NZ268110A (en) 1999-06-29
DE69430427T2 (de) 2002-11-14
DE706395T1 (de) 1997-09-04
PT706395E (pt) 2002-09-30
HU9503692D0 (en) 1996-02-28
FI956269A7 (fi) 1995-12-27
HU218949B (hu) 2001-01-29
LV12918B (en) 2003-03-20
US5834489A (en) 1998-11-10
NO955313L (no) 1995-12-27
CZ283300B6 (cs) 1998-02-18
ATE216237T1 (de) 2002-05-15
FI956269A0 (fi) 1995-12-27
HK1010344A1 (en) 1999-06-17
SK280111B6 (sk) 1999-08-06
CZ336495A3 (en) 1996-06-12
ES2099048T3 (es) 2002-11-16
IL110006A0 (en) 1994-11-11
BR9406865A (pt) 1996-03-26
IL110006A (en) 1999-01-26
LT3449B (en) 1995-10-25
CA2165446C (en) 2005-07-05
SA94150010B1 (ar) 2006-04-04
RU2152215C1 (ru) 2000-07-10
AU692161B2 (en) 1998-06-04
US5670524A (en) 1997-09-23
SK164695A3 (en) 1996-07-03
TW285640B (enExample) 1996-09-11
LTIP1958A (en) 1995-01-31
IS4174A (is) 1994-12-29
MY119360A (en) 2005-05-31
CN1126435A (zh) 1996-07-10
PL312198A1 (en) 1996-04-01
EP0706395B1 (en) 2002-04-17
AU7086694A (en) 1995-01-17
DE69430427D1 (de) 2002-05-23
PL175518B1 (pl) 1999-01-29
NO955313D0 (no) 1995-12-27
JP3725541B2 (ja) 2005-12-14
FI956269L (fi) 1995-12-27
SG49078A1 (en) 1998-05-18
DK0706395T3 (da) 2002-07-22
HUT75115A (en) 1997-04-28
SE9302218D0 (sv) 1993-06-28

Similar Documents

Publication Publication Date Title
EG22373A (en) New pharmaceutical formulation
IL113631A0 (en) New antagonist compounds
CA2186260A1 (en) Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide
TW285640B (enExample)
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
AU6053496A (en) The use of sertraline to treat post myocardial infarction patients
ZA965749B (en) Use of allylamines.
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
SE9404438D0 (sv) New process
HUT72329A (en) Application of riluzole as a radiorestorer